Urine test for kidney problem after transplant or biopsy
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a special urine test can detect kidney problems early in people who have had a kidney transplant or who have chronic or acute kidney disease. It requires a first-morning urine sample and regular check-ups at the study hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a kidney transplant at least 12 months ago, or you have chronic or acute kidney disease and have had a kidney biopsy.
- If you had a transplant, you are on standard anti-rejection medicines (calcineurin inhibitor, mycophenolate, and steroids).
- You are able to provide a first-morning urine sample and agree to regular check-ups at University Hospital Martin.
- You sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if a new urine test (u DKK3) can find signs of kidney transplant problems earlier than current tests. It looks at your kidney function over the first year after your transplant.
This study looks at changes in protein in the urine before and after a kidney transplant. It may help doctors better understand kidney health and monitoring after transplant.
This study will collect blood samples from people having a kidney biopsy or a kidney transplant to look for biomarkers (biological signs) that can give doctors more information about kidney health. Participating may help doctors better understand and treat kidney disease in the future.
This study is for people with a kidney transplant who are in the hospital for a biopsy because their doctor suspects rejection. Researchers want to see if a simple blood or urine test can detect rejection, which might make future biopsies less necessary.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
Hear when a new Transplant Recipient (Kidney) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.